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Inducer	 Concentration	 Induction	time	 NETosis	 Reference	
PMA	 4-50	nM	(3-30.8	ng/ml)	 10	min-16h	 Yes	 1-3,12,16,19,20,26-112	




	 100000	nM	(6168	ng/ml)	 10	min-24h	 Yes	 14,167,168	
H2O2	 0.1	µM	 3h	 No	 116	
	 100-1000	µM	 4h	 Yes	 61,114	
	 4000	µM		 200	min	 Apoptosis	 18	
	 10000	µM		 200	min	 Necrosis	 18	
	 10000	µM	 4-5h	 Yes	 54	




IL-8	 1-250	ng/ml	 10	min-5h		 Yes	 1,12,27,29,42,64,161,1
70-172	
	 10	ng/ml	 3h	 Little	 16	
	 100-800	ng/ml	 4-18h	 No	 18,76,82	
IL-1β	 10	ng/ml	 6h	 Little	 62	
	 50	ng/ml	 2h	 Yes	 27	
TNF-α	 1	ng/ml	 6h	 Little	 62	









Platelets	 5x107	/ml	 	 No	 10	





































A23187	 0.2-25	µM	 20	min-4h	 Yes	 22,130,151,177-179	
	 1	µM	 1h	 No	 180	
	 100	µM	 1-4h	 Little	 167	
Ionomycin	 0.9-7	µM		 30	min-4h	 Yes	 21,29,34,130,132	
	 100	µM	 1-4h	 Little	 167	
MSU	
crystals	
















100	mU/ml	 1-4h	 Yes	 12,172	
Glucose	 5.5-10	nM	 2h	 No	 183	
	 20-30	nM		 2h	 Yes	 183	
	 5000000	nM		 3h	 No	 58	
	
29	












	 0.1-25	µg/ml	 2,5-3h	 Little	 16,21	
	 0.3-5	µg/ml	 15	min	 No	 10,17	









	 	 30	min	 Yes	 196	
LPS	+	
Glucose	
2	µg/ml	+	30000000	nM	 3h	 Little	 19	






	 25-100	ml	+		 20	min	 Yes	 175	
β-glucan	 200	µg/ml	 15-240	min	 Yes	 198,199	
	 1000	µg/ml		 1h	 Yes	 129	
Bacteria/fungi	










S.	pneumonia	 10	MOI	 10	min-24h	 Yes	 14	
S.	pneumonia	
(dead)	
2x107/ml	 4h	 Yes	 118	
E.	coli		 	 4h	 No	 15	
	 3-50	MOI	 10	min-24h	 Yes	 14,34,79,124,202	
	 100	MOI	 1-4h	 Yes	 51,184	
	 106	-107	CFU	 5min-1h	 Yes	 189,203	
	 2000	CFU	 1-8h	 Yes	 189	







	 6x106/ml	 1h	 Yes	 180	
A.	fumigatus	
(hyphae)	





















































	 10	MOI	 3h	 Little	 120	























































































































		 n	 Time	(hr)	 p-value	
	 	 0	 1	 2	 3	 	
None	 5	 1.94	(0.43)	 3.8	(1.35)	 3.68	(1.08)	 4.10	(1.34)	 n.s.	
PMA	(250	ng/ml)	 7	 3.89	(0.91)	 7.81(1.64)	 31.94	(6.17)	 61.52	(9.34)	 <0.001	
LPS	(5	µg/ml)	 7	 2.98	(1.58)	 2.62	(1.26)	 2.90	(1.08)	 3.98	(1.69)	 n.s.	
Glucose	(25	mM)	 3	 4.71(1.06)	 4.92	(1.90)	 6.40	(1.98)	 6.58	(1.96)	 n.s.	
Platelets	(5x107)	 5	 2.53	(0.71)	 2.80	(1.12)	 1.12	(0.89)	 1.16	(0.92)	 n.s.	
Activated	Platelets	
(5x107)	
7	 2.00	(0.60)	 3.24	(1.15)	 1.45	(0.61)	 1.27	(0.47)	 n.s.	
Activated	Platelets	
Supernatant	(5x107)	
7	 2.84	(1.12)	 4.48	(1.19)	 5.68	(2.31)	 5.94	(2.45)	 n.s.	
Platelets	and	LPS	
(5x107	+	5	µg/ml)	
7	 2.60	(0.79)	 3.57	(0.72)	 2.43	(1.09)	 3.09	(0.98)	 n.s.	
Activated	Platelets	and	
LPS	(5x107	+	5	µg/ml)	


























































































































































































































































































































































































































































































































































































































































































































































































































































































































USA300		 ST8	 Clinical	Strain	 Sultan	et	al	












































































































































































































































































































































































































































































































































Newman	 ST8	 Laboratory	strain	 	














MW2	 ST1,	USA400	 Clinical	isolate	 	
Mu50	 ST5	 Clinical	isolate	 	
















































































































































































Nuc1	was	 significantly	 expressed	 by	M82	 (P	 ≤	 0.01),	M116	 (P	 ≤	 0.001)	 and	
RWW50	 (P	 ≤	 0.001)	 (Fig.	 1).	 Additionally,	 a	 positive	 correlation	 between	
nuclease	production	and	biofilm	mass	was	found	for	M82	(r=0.903;	p	=0.053),	
M116	 (r=0.813;	 p=0.187),	 8325-4	 (r=0.999;	 p=0.0002),	 RWW50	 (r=0.847;	
p=0.152)	 and	 for	 Newman	 (r=0.947;	 p=0.053)	 (Fig.	 1B-F).	 We	 further	
























I	 II	 III	 I	 II	 III	 I	 II	 III	
Newman	
t=4h	 5	 -		 -		 25.6	 -		 -		 100	 -		 -		
t=24h	 11	 3	 1	 40.8	 16.7	 6.58	 100	 100	 92,9	
RWW50	
(USA300)	
t=4h	 5	 5	 11	 21.1	 24.6	 46.9	 100	 100	 100	
t=24h	 16	 10	 -		 47.8	 36.8	 -		 100	 100	 -		




in	 conventional	 media	 and	 nuc-GFP	 transcription	 was	 noticeable	
approximately	after	10	hours	of	biofilm	incubation	in	BHI	media	24	or	while	6	
hours	 in	 TSB	 26,	 	 we	 setup	 an	 experiment	 in	 which	 we	 compared	 nuclease	
activity	in	biofilms	grown	in	both	TSB	and	IMDM.	Therefore,	we	
quantified	 nuclease	 activity	 for	 two	 hours	 in	 3	 hours	 old	 biofilms	 using	 a	
FRET-based	 assay.	 Here,	 we	 saw	 that	 nuclease	 activity	 of	 strains	 8325-4,	
M116,	Newman	and	MW2,	was	higher	when	grown	in	IMDM,	compared	to	the	
Nuclease	 activity	 of	 these	 strains	 in	 TSB	 (P	 ≤	 0.001)	 (Fig.	 2).	 Interestingly,	
strain	RWW50,	which	belongs	to	the	USA300	family,	and	strain	Mu50	show	no	
significant	 different	 in	 nuclease	 activity	 between	 these	 two	 growth	 media	
(p=0.05).	
	Figure	2:	Nuclease	production	by	biofilm	of	different	S.	aureus	strains	in	TSB	and	IMDM.	
FRET-based	 measurement	 of	 Nuclease	 production	 during	 the	 4th	 and	 the	 5th	 hour	 of	
biofilm	formation	of	S.	aureus	8325-4,	Newman,	M116,	RWW50,	MW2	and	Mu50	in	TSB	


















































































































Newman + PMN + Nuc
RWW50 + PMN + Nuc
PMN + Nuc
TBHP + PMN










































































































































































































































































































































































































Male	gender	(%)	 36	(58%)	 7	(64%)	 29	(59%)	 ns	
Age	(years)	 2.9	(1.8-9.6)	 2.2	(0.8-2.8)	 3.5	(1.9-10)	 0.08	
PRISM	score	 17	(10-25)	 25	(21-34)	 17	(12-24)	 0.003	





































































Fibrinogen	 0.035	(29)	 0.86	 0.037	(36)	 0.82	
Soluble	TNFr	 0.238	(17)	 0.36	 -	 -	
IL-1B	 0.391	(17)	 0.12	 -	 -	
IL-6	 0.326	(17)	 0.20	 -0.068	(20)	 0.78	




























































































































































































































































































































































































































	 	 Rs	 P	 Rs	 P	
VWF:Ag	 0.05	 0.38	 0.12*	 0.02	
VWF:CB		
	
0.05	 0.38	 0.03	 0.55	
VWF:CB/VWF:Ag		 -0.03	 0.65	 -0.15**	 0.004	
ADAMTS13	activity#		 0.01	 0.89	 -0.06	 0.36	
CRP		 0.29**	 <0.001	 0.15**	 0.006	
Nucleosomes		 0.11	 0.07	 0.13*	 0.02	
Age	 0.09	 0.12	 0.14**	 0.008	
BMI	 0.25**	 <0.001	 0.36**	 <0.001	
SBP	 0.06	 0.32	 0.03	 0.56	
DBP	 0.04	 0.55	 0.02	 0.78	
Cholesterol†	 0.20**	 0.001	 N.A.#	 N.A.#	














































controls	 n,	cases	 OR	 95%CI	 OR	 95%CI	
Q1	 <268	 73	 65	 1	(ref)	 		 1	(ref)	 		




















Q1	 <0.99	 73	 121	 1	(ref)	 		 1	(ref)	 		



















	 	 	 	 	















Q4	 >185	 55	 29	 1	(ref)	 		 1	(ref)	 		
CRP	(mg/ml)		
	 	 	 	 	 	
Q1	 <0.26	 73	 76	 1	(ref)	 		 1	(ref)	 		
















	 	 	 	
D1	 <5	 207	 240	 1	(ref)	 		 1	(ref)	 		

































































been	 suggested	 that	 both	 FH	 and	 CRP	 interact	 with	 oxidized	 phospholipids	
that	 arise	 during	 inflammation,	 which	 form	 damage-associated	 molecular	
patterns	 (DAMP)	 that	 activate	 the	 innate	 immune	 system	 19.	 The	 authors	 of	
that	 study	 speculate	 that	 this	 recognition	 may	 enable	 the	 innate	 immune	
system	to	mediate	important	physiological	housekeeping	functions,	including	
the	 removal	of	dying	 cells.	 Indeed,	FH	was	also	 correlated	with	extracellular	
nucleosome	 levels,	 a	 marker	 of	 cell	 death,	 in	 our	 patients.	 Extracellular	
nucleosomes	 in	 the	 blood	 may	 potentially	 also	 be	 derived	 from	 neutrophil	
extracellular	 traps	 (NETs)	 that	 are	 released	 in	 inflammation	 and	 which	 are	
known	contributors	to	both	venous	and	arterial	thrombosis20.	Of	interest,	FH	
has	 been	 implicated	 in	 the	 regulation	 of	 NETs	 formation,	 although	 no	 such	
effect	was	observed	with	soluble	rather	than	immobilized	FH	21.	However,	the	
extracellular	 nucleosome	 levels	 in	 our	 study	 population	were	 low	 and	 often	
even	 below	 the	 detection	 limit,	 probably	 because	 plasma	 samples	 were	
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